MarketWatch
중도 성향
기타
Tired of nausea or taking a GLP-1 pill every day? These experimental drugs could be better than Zepbound and Wegovy.
There is a new wave of weight-loss therapies in development that aim to be better than the existing GLP-1s.
MarketWatch · "TAKING" · 총 8건
필터 보기현재 지수
50.0
0 = 부정 우세
50 = 중립
100 = 긍정 우세
최근 7일 기준 178건을 분석한 결과, 뉴스 심리지수는 50.0(균형)입니다. 긍정 0건(0.0%)·중립 178건(100.0%)·부정 0건(0.0%)이며, 중립 비중이 뚜렷하게 높습니다. 성향 지수는 종합 0.0(중도 균형)입니다.
There is a new wave of weight-loss therapies in development that aim to be better than the existing GLP-1s.
The May jobs report blew past forecasts. Why is it taking six months to find a new job?
While U.S. stocks have kept notching record highs, bitcoin is sliding to its weakest level in months.
Dating was already expensive, but high gas prices have people narrowing their dating-app radius and taking other extreme measures
Investors were expecting a “more material beat and raise” than what Ciena delivered with its latest earnings report, one analyst says.
Analysts attribute the stock drop to profit-taking, the timing of AI contributions and changes to reporting conventions.
Earnings are the principal driver behind the breathtaking rallies achieved by Korean and Taiwanese benchmark indices in 2026, and Goldman Sachs thinks the market is still underestimating the longevity of the chip cycle.
Unpaid family work is costing caregivers $1,000 a month. Here is how Congress wants to help them catch up.